Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Postdoctoral Researcher in Multimodal Reasoning Models for Oncology We are seeking an exceptional and highly motivated Postdoctoral Researcher to lead research on multimodal reasoning models for oncology. The project focuses on developing, post‑training, and evaluating flexible
We are seeking an exceptional and highly motivated Postdoctoral Researcher to lead research on multimodal reasoning models for oncology. The project focuses on developing, post-training, and evaluating flexible AI models that can support complex oncologic diagnostic